Neuralink Initiates First Global Brain Chip Trial

Neuralink, co-founded by Elon Musk, has started its first clinical trial of brain chips at Toronto Western Hospital, following approval from Health Canada. The trials aim to assist patients with severe paralysis in controlling devices solely through their thoughts.

The technology intends to enable individuals with quadriplegia to control devices purely with their minds.

Since 2016, when Musk announced his goals to merge the human brain with machines, Neuralink has been pursuing this technology. The company recently began its first human trials, with early results showing significant improvements in patients’ abilities to interact with video games and 3D design software.

Despite significant progress, Neuralink has faced challenges, including concerns over its animal testing protocols. However, the company continues to strive to provide new possibilities for individuals with neurological issues.

English: #Neuralink #ElonMusk #MedicalTechnology #Paralysis #BrainChip #ClinicalTrial